Press Releases from AplaGen GmbH (2 total)
AplaGen announces publication of a patent application for a novel technology tha …
AplaGen announces publication of a patent application for a novel technology that increases half-life of proteins in vivo
Baesweiler, Germany, December 7, 2009 - AplaGen GmbH announced today the publication of a patent application describing an innovative method for increasing the half-life of complex and/or multifunctional proteins in human and animal circulation in order to reduce infusion rates and increase patient quality of life. Large proteins that undergo high levels of…
direct/ AplaGen GmbH (DE) - AplaGen GmbH acquires capital to ensure growth chanc …
NRW.Bank and IVC enlarge their former engagement.
Baesweiler, 2006, February 21st.
AplaGen has closed a Convertible Bond with NRW.Bank.Venture Fonds and the IVC Intelligent Venture Capital Fonds. The investors have enlarged their former engagement in the biotechnology company AplaGen GmbH. With this funding, further growth chances of the company based in Baesweiler are ensured and it is strengthened on its way to out-license its first product.
AplaGen´s product pipeline includes…
